Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Return on Capital Employed (2019 - 2025)

Precision Biosciences (DTIL) has disclosed Return on Capital Employed for 7 consecutive years, with 1.04% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 93.0% to 1.04% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.04%, a 93.0% decrease, with the full-year FY2024 number at 0.2%, up 10.0% from a year prior.
  • Return on Capital Employed was 1.04% for Q3 2025 at Precision Biosciences, down from 0.87% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.05% in Q2 2024 to a low of 1.04% in Q3 2025.
  • A 5-year average of 0.35% and a median of 0.25% in 2024 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: soared 73bps in 2021, then tumbled -93bps in 2025.
  • Precision Biosciences' Return on Capital Employed stood at 0.21% in 2021, then decreased by -29bps to 0.28% in 2022, then tumbled by -41bps to 0.39% in 2023, then soared by 48bps to 0.2% in 2024, then plummeted by -415bps to 1.04% in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Return on Capital Employed are 1.04% (Q3 2025), 0.87% (Q2 2025), and 0.37% (Q1 2025).